K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers
暂无分享,去创建一个
[1] C. Moskaluk,et al. Homozygous deletion map at 18q21.1 in pancreatic cancer. , 1996, Cancer research.
[2] Scott E. Kern,et al. DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.
[3] Y. Shiratori,et al. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. , 1996, Gastroenterology.
[4] J. Minna,et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. , 1995, JAMA.
[5] A. Gazdar,et al. K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. , 1994, Cancer research.
[6] R. Hruban,et al. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. , 1994, Cancer research.
[7] C Caldas,et al. Allelotype of pancreatic adenocarcinoma. , 1994, Cancer research.
[8] J. Cameron,et al. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. , 1994, The American journal of pathology.
[9] H. Adami,et al. Pancreatitis and pancreatic cancer: a population-based study. , 1994, Journal of the National Cancer Institute.
[10] D. Shibata,et al. Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma. , 1994, Cancer research.
[11] N. Pellegata,et al. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. , 1994, Cancer research.
[12] S. Maeda,et al. The role ofras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis , 1993 .
[13] J. Bernaudin,et al. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. , 1993, Journal of the National Cancer Institute.
[14] N. Lemoine,et al. Abnormalities affecting the APC and MCC tumour suppressor gene loci on chromosome 5q occur frequently in gastric cancer but not in pancreatic cancer , 1993, International journal of cancer.
[15] S. Goodman,et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. , 1993, The American journal of pathology.
[16] J. Bishop,et al. Predisposition to neoplastic transformation caused by gene replacement of H-ras1. , 1993, Science.
[17] S. Hirohashi,et al. Pancreatic adenocarcinomas frequently show p53 gene mutations. , 1993, The American journal of pathology.
[18] A. Berchuck,et al. Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma. , 1993, Cancer research.
[19] R. Padmanabhan,et al. K-ras and p53 point mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced hamster lung tumors. , 1993, Carcinogenesis.
[20] A. Yanagisawa,et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. , 1993, Cancer research.
[21] T. Urano,et al. Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. , 1993, Annals of surgery.
[22] M. Leppert,et al. A CA-repeat polymorphism close to the adenomatous polyposis coli (APC) gene offers improved diagnostic testing for familial APC. , 1993, American journal of human genetics.
[23] S Ichii,et al. Frequent somatic mutations of the APC gene in human pancreatic cancer. , 1992, Cancer research.
[24] N. Nadon,et al. Polymerase chain reaction microanalysis of tumors from stained histological slides. , 1992, Oncogene.
[25] J. Boyd,et al. Dinucleotide repeat polymorphism in the human DCC gene at chromosome 18q21. , 1992, Human molecular genetics.
[26] Kathleen R. Cho,et al. Genetic alterations in the adenoma–carcinoma sequence , 1992, Cancer.
[27] R. Weinel,et al. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. , 1992, Cancer research.
[28] A. Todd,et al. Estimation of the proportions of mutant and normal N-ras alleles by allele specific restriction analysis. , 1992, Nucleic acids research.
[29] N. Lemoine,et al. Ki-ras oncogene activation in preinvasive pancreatic cancer. , 1992, Gastroenterology.
[30] K. Kinzler,et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.
[31] S. Altschul,et al. Identification of FAP locus genes from chromosome 5q21. , 1991, Science.
[32] J. Minna,et al. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. , 1991, Oncogene.
[33] J. L. Bos,et al. ras oncogenes in human cancer: a review. , 1989, Cancer research.
[34] R. Weinberg,et al. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. , 1989, Cancer research.
[35] J. Guillem,et al. Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer. , 1989, Oncogene.
[36] C. Bartram,et al. High frequency of Ki‐ras codon 12 mutations in pancreatic adenocarcinomas , 1989, International journal of cancer.
[37] Y. Nakamura,et al. Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.
[38] D. Shibata,et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes , 1988, Cell.
[39] V. Rotter,et al. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation , 1984, Nature.
[40] D. Ilstrup,et al. Total pancreatectomy for ductal adenocarcinoma of the pancreas. Mayo Clinic experience. , 1981, American journal of surgery.
[41] S. Saga,et al. Relation of pancreatic duct hyperplasia to carcinoma , 1979, Cancer.
[42] S. Bengmark,et al. Total Pancreatectomy for Cancer An appraisal of 65 cases , 1977, Annals of surgery.
[43] D. Slaughter,et al. “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin , 1953, Cancer.